GlobeNewswire Inc.··Milestone Pharmaceuticals Inc.Milestone Pharma Launches Real-World Evidence Registry for CARDAMYST Following FDA Approval
Milestone Pharmaceuticals launches RESET-PSVT real-world evidence registry for FDA-approved CARDAMYST nasal spray, enrolling 450 patients across 20 sites beginning end of 2026.
MISTFDA approvalreal-world evidence